Image Not Found On Media Library
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Pre-Order CRaFT 2025
    • 2024 CRaFT Report
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-r
Image Not Found On Media Library
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Pre-Order CRaFT 2025
    • 2024 CRaFT Report
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

MORSE Consulting Welcomes a Strategic Partner and a New Team Member!

May 1, 2017
-
What's New
-
Posted by MORSE Team - 2 min read.

Toronto, May 1, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce a strategic partnership with Brent Korte of Impact Consulting as well as to welcome a new MORSE team member, Avery Hughes as a Reimbursement Strategist.

Brent Korte has more than 25 years of experience in pharmaceutical industry and consulting with both national and regional expertise in health policy government relations, market access, strategy development and implementation expertise in the provinces. Brent possesses multi-therapeutic experience and expertise in oncology, immunology, biologics, biosimilars, etc.) and is known as a consensus builder striving to establish strategic and constructive partnerships with pharmaceutical stakeholders while building trusting business relationships.

“As one of MORSE’s strategic partners, I offer complementary skills and experience while sharing core fundamental values of trust and integrity with the MORSE team” said Korte. “I thrive in a team environment and am confident that the collaboration between IMPACT and MORSE will offer significant value to our clients.”

As a Health Policy Consultant, Brent provides strategic advice to MORSE clients related to commercialization, stakeholder/government relations, corporate communication strategy and PLA implementation.

Avery Hughes has more than 2 years of work experience in pharmaceutical reimbursement consulting and has a background in health services research and economics. Her past work experience includes working as a Research Assistant for Health Canada and as an intern in the procurement division of Johnson & Johnson Medical Companies.  Avery has assisted in the development of several research reports focusing on an array of topics including biosimilars, cost-utility analyses, the pan-Canadian Pharmaceutical Alliance (pCPA), product listing agreements, and drug pricing policy in the Canadian market.

“I have always been fascinated by the interplay of economics and healthcare and believe that MORSE provides me with an excellent opportunity to better understand both these spheres” said Hughes.  “I see my role at MORSE as one that not only applies a rigorous analytical approach to current market access problems and continually looks for opportunities to better understand emerging issues in Canadian pharmaceutical reimbursement.”

As Reimbursement Strategist, Avery’s role is to provide research and consulting support to the MORSE team.

We are excited to welcome these two individuals to MORSE and are confident that they will help strengthen our service offerings and vision to be a leader in strategic pharmaceutical reimbursement consulting with a reputation for honesty, integrity, and collaboration.

 

Share
Tags
Health Policy Consultant
MORSE Team
Reimbursement strategy
← PREVIOUS POST
pCPA Update as of April 30, 2017
NEXT POST →
Release of the ODB Program’s 2015/16 Annual Report Card

Contact Us

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

Pre-Order 2025 Report

2025 Canadian Reimbursement and Forecasting Timelines Report

Social
Connect & Follow:
Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Welcomes a Strategic Partner and a New Team Member!
Learn More
Learn More